Masahiko Kondo
Otsu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Efficacy of Lenvatinib as Subsequent Therapy After Combination Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma.
Journal: Anticancer research
Published: May 14, 2026
Sofosbuvir/Velpatasvir in Chronic Hepatitis C, Compensated and Decompensated Cirrhosis, and Retreatment Settings.
Journal: Internal medicine (Tokyo, Japan)
Published: January 04, 2026
Effect of Direct-Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in Japan.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: August 11, 2025
Effect of Pemafibrate on Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationwide Multicenter Study.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: July 17, 2025
Head-to-Head Comparison of Long-Term HCC Risk of Antivirals-Treated Versus Untreated Low-Level Viremia in HBV-Compensated Cirrhosis.
Journal: Journal of gastroenterology and hepatology
Published: December 15, 2024
Pemafibrate improves liver biochemistry and GLOBE scores in patients with primary biliary cholangitis: Nationwide, multicenter study by the Japanese Red Cross Liver Study Group.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: October 07, 2024
Treatment response to durvalumab plus tremelimumab after progression with previous immune checkpoint inhibitor in unresectable hepatocellular carcinoma.
Journal: Investigational new drugs
Published: July 17, 2024
Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection who had received direct-acting antiviral therapy.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 23, 2024
Effect of treatment periods on efficacy of glecaprevir and pibrentasvir in chronic hepatitis C: A nationwide, prospective, multicenter study.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: January 15, 2024
Necessity for surveillance for hepatocellualr carcinoma in older patients with chronic hepatitis C who achieved sustained virological response.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: March 22, 2023
Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross Liver Study Group.
Journal: Investigational new drugs
Published: January 14, 2023
Last Updated: 09/26/2026